English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background  Transforming growth factor-β1 (TGF-β1) is an important regulator of cell migration and plays a role in the scarring response in injured brain. It is also reported that 5-lipoxygenase (5-LOX) and its products, cysteinyl leukotrienes (CysLTs, namely LTC 4 , LTD 4  and LTE 4 ), as well as cysteinyl leukotriene receptor 1 (CysLT 1 R) are closely associated with astrocyte proliferation and glial scar formation after brain injury. However, how these molecules act on astrocyte migration, an initial step of the scarring response, is unknown. To clarify this, we determined the roles of 5-LOX and CysLT 1 R in TGF-β1-induced astrocyte migration.    Methods  In primary cultures of rat astrocytes, the effects of TGF-β1 and CysLT receptor agonists on migration and proliferation were assayed, and the expression of 5-LOX, CysLT receptors and TGF-β1 was detected. 5-LOX activation was analyzed by measuring its products (CysLTs) and applying its inhibitor. The role of CysLT 1 R was investigated by applying CysLT receptor antagonists and CysLT 1 R knockdown by small interfering RNA (siRNA). TGF-β1 release was assayed as well.    Results  TGF-β1-induced astrocyte migration was potentiated by LTD 4 , but attenuated by the 5-LOX inhibitor zileuton and the CysLT 1 R antagonist montelukast. The non-selective agonist LTD 4  at 0.1 to 10 nM also induced a mild migration; however, the selective agonist N-methyl-LTC 4  and the selective antagonist Bay cysLT2 for CysLT 2 R had no effects. Moreover, CysLT 1 R siRNA inhibited TGF-β1- and LTD 4 -induced astrocyte migration by down-regulating the expression of this receptor. However, TGF-β1 and LTD 4  at various concentrations did not affect astrocyte proliferation 24 h after exposure. On the other hand, TGF-β1 increased 5-LOX expression and the production of CysLTs, and up-regulated CysLT 1 R (not CysLT 2 R), while LTD 4  and N-methyl-LTC 4  did not affect TGF-β1 expression and release.    Conclusions  TGF-β1-induced astrocyte migration is, at least in part, mediated by enhanced endogenous CysLTs through activating CysLT 1 R. These findings indicate that the interaction between the cytokine TGF-β1 and the pro-inflammatory mediators CysLTs in the regulation of astrocyte function is relevant to glial scar formation.

Transforming growth factor β1-induced astrocyte migration is mediated in part by activating 5-lipoxygenase and cysteinyl leukotriene receptor 1